Ledger.Open graph →
SEC Form D · filed October 21, 2022

NX Pharmagen Inc

Offering
$1.0M
Sold
$590K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOUISVILLE, KY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Alan M. Ezrin · Louisville, KYDirectorRobert Saunders · Louisville, KYDirectorBrian Brohman · Louisville, KYExec · DirectorMatthew George · Boston, MADirectorJeffery A. Sugg · Troy, MIDirectorJill A. Vogel · Troy, MIExec · DirectorMark C. Griege · DALLAS, TXDirectorTom B. Fortin · NEW YORK, NYDirectorTodd B. Myers · NEW YORK, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗